arrow
D

David Erritzøe

imperial college london
H指数:55
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trait absorption association with ketamine’s benefits and drug-context interactions in treatment-resistant depression: exploratory results from the MUSIK randomized clinical trial

特质吸收与氯胺酮疗效及药物-情境交互作用在难治性抑郁症中的关系:MUSIK随机临床试验的探索性结果

2026-11-140
OAAI
The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression

亚麻醉剂量氯胺酮输注随机临床试验的音乐:氯胺酮作为致幻剂治疗高度难治性抑郁症

2026-04-170
OAAI
How to set up a psychedelic study: Unique considerations for research involving human participants

如何设立一项迷幻研究:涉及人类参与者的独特考量

2026-03-230
OAAI
Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach

检测健康人类受试者中由氯胺酮诱导的神经可塑性效应:一种多模态方法

2026-03-210
OA
A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial

针对重度抑郁症的短效致幻剂干预:一项IIa期随机安慰剂对照试验

2026-02-011
OA
The Effect of Psychedelics on Individuals with a Personality Disorder: Results from Two Prospective Cohort Studies

致幻剂对人格障碍个体的影响:两项前瞻性队列研究的结果

2025-12-010
PRE
Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat

参与裸盖菇素静修活动后,有创伤性脑损伤病史的退伍军人表现出改善的精神健康结果和正常化的自发电脑电图活动。

2025-08-060
OA
Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study

单次剂量(10 mg)裸盖菇素可减轻强迫症成年患者的症状:一项药理学挑战研究

2025-07-010
OAAI
A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy

致幻剂、心理溶解剂和情感觉察剂辅助心理治疗的模型培训课程

2025-06-100
PRE
Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness

探索5-MeO-DMT作为解构意识的药理学模型

2025-04-211
OA